• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    QT Imaging Holdings Announces Clearing of All Its Short-Term Liabilities and Forecasts Solid Revenue Growth

    1/13/25 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $QTI alert in real time by email

    QT Imaging Holdings, Inc. (NASDAQ:QTI) (the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce strengthening of its financials, by clearing its short-term liabilities and by forecasting solid revenue growth in 2025 and 2026.

    The Company announced amendments to both its convertible promissory note with YA II PN, Ltd. (the "YA Investor," and such promissory note, the "YA Note") and to its convertible promissory note with Funicular Funds, LP (the "Cable Car Investor," and such promissory note, the "Cable Car Note"), each of which was entered into on January 9, 2025. With the amendments of YA Note and Cable Car Note, both notes are maturing on March 31, 2026, by which date the outstanding principal balance and the annual interest of 6% are due. No payments whatsoever are to be made by the Company till that date. Comprehensive details of both agreements are included in the Form 8-K filed by the Company with the SEC on January 10, 2025.

    Additionally, the Company forecasts revenue of $18M in 2025 and $27M in 2026, a significant increase from 2024 revenue.

    "On behalf of the QTI leadership team and Board of Directors, I would like to thank the YA Investor and Cable Car Investor teams for their partnership and trust, as the execution of these amendments gives the QTI team the runway to successfully execute on our quarterly plan to deliver a minimum of 40 scanners in 2025, and 60 scanners in 2026, for a total of $45M in revenue for both years," said Dr. Raluca Dinu, Chief Executive Officer.

    About QT Imaging Holding, Inc.

    QT Imaging Holdings, Inc. is a public (NASDAQ:QTI) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient's experience. For more information on QT Imaging Holdings, Inc., please visit the company's website at www.qtimaging.com.

    Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as "will," and "expect," or the negative thereof or comparable terminology, and include (without limitation) statements regarding future payments by QT Imaging Holdings under the YA Note and the Cable Car Note, plans for QT Imaging Holdings, new product development and introduction, and product sales growth and projected revenues. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. These risks include, but are not limited to: research results from the use of the Breast Acoustic CT™ Scanner, the ability of QT Imaging Holdings to sell and deploy the Breast Acoustic CT™ Scanner, the ability to extend product offerings into new areas or products, the ability to commercialize technology, unexpected occurrences that deter the full documentation and "bring to market" plan for products, trends and fluctuations in the industry, changes in demand and purchasing volume of customers, unpredictability of suppliers, the ability to attract and retain qualified personnel and the ability to move product sales to production levels. Additional factors that could cause actual results to differ are discussed under the heading "Risk Factors" and in other sections of QT Imaging Holding's (and its predecessor, GigCapital5, Inc.) filings with the SEC, and in its other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to QT Imaging Holdings as of the date hereof, and QT Imaging Holdings assumes no obligation to update any forward-looking statement.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250113427567/en/

    For media inquiries, please contact:

    Stas Budagov

    Chief Financial Officer

    [email protected]

    Get the next $QTI alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $QTI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $QTI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Greene James S bought $250,000 worth of shares (428,082 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:04:44 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Dickson Daniel H bought $50,000 worth of shares (85,616 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:54 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chairman Katz Avi S bought $1,834,999 worth of shares (3,142,122 units at $0.58), increasing direct ownership by 252% to 657,960 units (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:30 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    QT Imaging Holdings Introduces Machine Learning-Enabled Image Interpolation Algorithm to Substantially Reduce Scan Time

    QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QTI") a medical device company engaged in research, development, and commercialization of innovative body imaging systems is pleased to announce the release of a machine learning-enabled image interpolation algorithm designed to significantly reduce scan times by approximately 50%. This advancement is expected to enhance patient comfort by decreasing time spent on the scanner and improve operational efficiency by increasing the number of patients scanned within a given timeframe. The advanced machine learning algorithm enables sophisticated image interpolation, allowing the system to skip every other scan level while accurately preserving high imag

    1/14/25 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Holdings Announces Clearing of All Its Short-Term Liabilities and Forecasts Solid Revenue Growth

    QT Imaging Holdings, Inc. (NASDAQ:QTI) (the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce strengthening of its financials, by clearing its short-term liabilities and by forecasting solid revenue growth in 2025 and 2026. The Company announced amendments to both its convertible promissory note with YA II PN, Ltd. (the "YA Investor," and such promissory note, the "YA Note") and to its convertible promissory note with Funicular Funds, LP (the "Cable Car Investor," and such promissory note, the "Cable Car Note"), each of which was entered into on January 9, 2025. With the amendments of YA

    1/13/25 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Holdings Announces New Commercial Shipment in Partnership with Couri Center

    QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems is pleased to announce expansion of locations offering the Breast Acoustic CTTM Scanner to Couri Center for Gynecology and Integrative Women's Health, in Peoria, IL. The shipment was made together with our strategic business and distribution partner, NXC Imaging, Inc. "Our partnership with QTI marks a pivotal moment in breast imaging technology. With the QTI Breast Acoustic CTTM System, patients can experience an enhanced approach to breast imaging that prioritizes comfort and safety without compromising image quality," stated Jon Stoa,

    12/12/24 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    SEC Filings

    View All

    SEC Form S-8 filed by QT Imaging Holdings Inc.

    S-8 - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

    2/12/25 4:15:47 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form EFFECT filed by QT Imaging Holdings Inc.

    EFFECT - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

    2/6/25 12:15:06 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 424B3 filed by QT Imaging Holdings Inc.

    424B3 - QT IMAGING HOLDINGS, INC. (0001844505) (Filer)

    2/5/25 4:30:33 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Greene James S bought $250,000 worth of shares (428,082 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:04:44 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Dickson Daniel H bought $50,000 worth of shares (85,616 units at $0.58) (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:54 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Chairman Katz Avi S bought $1,834,999 worth of shares (3,142,122 units at $0.58), increasing direct ownership by 252% to 657,960 units (SEC Form 4)

    4 - QT IMAGING HOLDINGS, INC. (0001844505) (Issuer)

    11/14/24 9:03:30 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Leadership Updates

    Live Leadership Updates

    View All

    QT Imaging Announces First Quarter 2024 Financial Results

    Generated Scanner Sales Revenue of $1.4M with 56% Gross Margin in the First Quarter of 2024, Since the Company Became Public on March 4th Streamlined Business Model via Strategic Sales and Distribution Partnership in USA Reported in Academic Radiology the Results of a Second Blinded Screening Trial That Found That QTI Technology Is Similarly Effective as Digital Breast Tomosynthesis (DBT) or 3D Mammography Company Completed Merger with GigCapital5 QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the first qu

    5/10/24 8:57:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Financials

    Live finance-specific insights

    View All

    QT Imaging Announces Third Quarter 2024 Financial Results

    Generated Scanner Sales Revenue of $0.9 Million with 65% Gross Margin in the Third Quarter of 2024 The Company Successfully Completed the Engineering and Clinical Feasibility Study with its Strategic Partner The Company Announced Entering into Favorable Amendments to Its $10 Million Convertible Promissory Note with YA II PN, Ltd. The Company Announced Insiders PIPE investment of $2.56 Million, fully funded by the QTI Board of Directors members and their Affiliates QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results

    11/13/24 8:32:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    QT Imaging Announces Second Quarter 2024 Financial Results

    Generated Scanner Sales Revenue of $1.7 Million with 51% Gross Margin in the Second Quarter of 2024 The Company Continues to Make Progress in the Engineering and Clinical Feasibility Study with its Strategic Partner Signed a U.S. Exclusive Distribution Agreement Announced Partnership with the University of Oklahoma and OU Health Stephenson Cancer Center to Improve Precision in Cancer Detection and Treatment QT Imaging Holdings, Inc. (NASDAQ:QTI) ("QT Imaging" or the "Company"), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the second quarter of 2024. "QT Imaging's team comp

    8/8/24 8:30:00 AM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $QTI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by QT Imaging Holdings Inc.

    SC 13D/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    11/22/24 4:15:11 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by QT Imaging Holdings Inc.

    SC 13G - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    11/14/24 4:01:08 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13D/A filed by QT Imaging Holdings Inc.

    SC 13D/A - QT IMAGING HOLDINGS, INC. (0001844505) (Subject)

    9/13/24 4:23:43 PM ET
    $QTI
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care